Legal Representation
Attorney
Pina Campagna
USPTO Deadlines
Next Deadline
1084 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2022-07-12)
Due Date
July 12, 2028
Grace Period Ends
January 12, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
16 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jul 12, 2022 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Jul 12, 2022 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Apr 26, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Apr 26, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Apr 6, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Mar 23, 2022 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Mar 23, 2022 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Mar 23, 2022 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Mar 23, 2022 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Mar 23, 2022 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Mar 22, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 20, 2021 | AMPX | O | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | Loading... |
| Sep 17, 2021 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Sep 12, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jul 12, 2021 | PARI | I | TEAS VOLUNTARY AMENDMENT RECEIVED | Loading... |
| Jul 3, 2021 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for ophthalmic use; medicinal preparations and substances for ophthalmic use; liquid and semisolid pharmaceutical compositions for the treatment of eye diseases; eye drops; pharmaceutical preparations for the treatment of the dry eye disease; pharmaceutical preparations for dermatological use; medicinal preparations and substances for dermatological use; liquid and semisolid pharmaceutical compositions for the treatment of skin diseases
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005